- Home
- TVTX vs ETV Comparison
TVTX vs ETV Comparison
Compare TVTX & ETV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- ETV
- Stock Information
- Founded
- TVTX 2008
- ETV 2005
- Country
- TVTX United States
- ETV United States
- Employees
- TVTX N/A
- ETV N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- ETV Investment Managers
- Sector
- TVTX Health Care
- ETV Finance
- Exchange
- TVTX Nasdaq
- ETV Nasdaq
- Market Cap
- TVTX 1.7B
- ETV 1.4B
- IPO Year
- TVTX N/A
- ETV N/A
- Fundamental
- Price
- TVTX $15.02
- ETV $13.61
- Analyst Decision
- TVTX Strong Buy
- ETV
- Analyst Count
- TVTX 14
- ETV 0
- Target Price
- TVTX $33.31
- ETV N/A
- AVG Volume (30 Days)
- TVTX 1.9M
- ETV 252.5K
- Earning Date
- TVTX 05-01-2025
- ETV 01-01-0001
- Dividend Yield
- TVTX N/A
- ETV 8.75%
- EPS Growth
- TVTX N/A
- ETV N/A
- EPS
- TVTX N/A
- ETV N/A
- Revenue
- TVTX $273,533,000.00
- ETV N/A
- Revenue This Year
- TVTX $74.41
- ETV N/A
- Revenue Next Year
- TVTX $48.90
- ETV N/A
- P/E Ratio
- TVTX N/A
- ETV N/A
- Revenue Growth
- TVTX 75.65
- ETV N/A
- 52 Week Low
- TVTX $6.79
- ETV $11.05
- 52 Week High
- TVTX $25.29
- ETV $13.50
- Technical
- Relative Strength Index (RSI)
- TVTX 35.45
- ETV 60.98
- Support Level
- TVTX $16.37
- ETV $13.10
- Resistance Level
- TVTX $15.48
- ETV $13.55
- Average True Range (ATR)
- TVTX 1.00
- ETV 0.19
- MACD
- TVTX -0.51
- ETV 0.02
- Stochastic Oscillator
- TVTX 3.83
- ETV 93.70
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
About ETV Eaton Vance Corporation Eaton Vance Tax-Managed Buy-Write Opportunities Fund of Beneficial Interest
Eaton Vance Tax-Managed Buy-Write Opp is a United States-based diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of common stocks, designated segments of which seek to exceed the total return performance of the S&P 500 and the NASDAQ-100.